Cargando…
Circulating HER-2 mRNA in the peripheral blood as a potential diagnostic and prognostic biomarker in females with breast cancer
Breast cancer is a prevalent malignant cancer worldwide, and a lack of defined biomarkers for early prognostication contributes to its high associated mortality rate, especially in human epidermal growth factor receptor 2 (HER-2)-positive breast cancer. In the present study, HER-2 mRNA levels in pat...
Autores principales: | Wu, Yanlin, Meng, Qiping, Yang, Zhixue, Shi, Lili, Hu, Rongkuan, Zhang, Peizhuo, Wei, Jinrong, Ren, Jie, Leng, Bingjing, Xu, Dong, Jiang, Guo-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096115/ https://www.ncbi.nlm.nih.gov/pubmed/30127983 http://dx.doi.org/10.3892/ol.2018.9091 |
Ejemplares similares
-
Surgical excision and oncoplastic breast surgery in 32 patients with benign phyllodes tumors
por: Ren, Jie, et al.
Publicado: (2018) -
INK4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma
por: Liu, Hui, et al.
Publicado: (2022) -
Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2021) -
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
por: Hamam, Rimi, et al.
Publicado: (2017) -
Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
por: Jin, Yu, et al.
Publicado: (2019)